KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 4,410 | -0.5% | 0.00% | – |
| Q2 2022 | $1,000 | -99.8% | 4,432 | -99.1% | 0.00% | – |
| Q1 2022 | $662,000 | +7.1% | 479,948 | -6.0% | 0.00% | – |
| Q4 2021 | $618,000 | +494.2% | 510,642 | +1183.2% | 0.00% | – |
| Q3 2021 | $104,000 | -82.0% | 39,795 | -63.4% | 0.00% | – |
| Q2 2021 | $577,000 | -19.7% | 108,812 | +2.0% | 0.00% | – |
| Q1 2021 | $719,000 | -78.4% | 106,714 | -78.2% | 0.00% | – |
| Q4 2020 | $3,326,000 | -13.9% | 490,559 | -4.8% | 0.00% | -100.0% |
| Q3 2020 | $3,865,000 | -7.1% | 515,264 | +30.2% | 0.00% | 0.0% |
| Q2 2020 | $4,160,000 | +21.8% | 395,764 | +1.9% | 0.00% | 0.0% |
| Q1 2020 | $3,415,000 | +1203.4% | 388,421 | +448.1% | 0.00% | – |
| Q4 2019 | $262,000 | -13.2% | 70,868 | -11.1% | 0.00% | – |
| Q3 2019 | $302,000 | -46.2% | 79,710 | -9.4% | 0.00% | – |
| Q2 2019 | $561,000 | -85.3% | 87,943 | -80.9% | 0.00% | -100.0% |
| Q1 2019 | $3,814,000 | +1516.1% | 461,020 | +854.1% | 0.00% | – |
| Q4 2018 | $236,000 | -69.8% | 48,319 | -39.0% | 0.00% | – |
| Q3 2018 | $781,000 | -25.8% | 79,154 | +3.3% | 0.00% | – |
| Q2 2018 | $1,052,000 | -8.6% | 76,625 | +5.3% | 0.00% | – |
| Q1 2018 | $1,151,000 | -6.0% | 72,745 | +9.8% | 0.00% | – |
| Q4 2017 | $1,225,000 | +750.7% | 66,250 | +949.9% | 0.00% | – |
| Q3 2017 | $144,000 | – | 6,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |